NHRA reduces drug approval processing time

TDT | Manama

Email: mail@newsofbahrain.com

Pharmaceutical companies in Bahrain will now face shorter waiting times to update registered medicines following a service upgrade aimed at speeding up approvals and improving efficiency.

The National Health Regulatory Authority (NHRA) enhanced its system for processing changes to registered medicines, reducing timelines and strengthening regulatory checks.

Under the new framework, major changes will be processed within 40 working days, down from 45, while minor changes can be approved within seven working days.

Applications can now be submitted electronically through the “Adwiyah” system, allowing companies to upload documents, pay fees and receive approvals digitally.

The authority said the improvements also streamline procedures by reducing approval layers, standardising service information and increasing transparency.